Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

TriSalus Life Sciences Stock

Q: Can you buy TriSalus Life Sciences stock?

You can no longer buy TriSalus Life Sciencesstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

trisaluslifesci.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $198.81MM

TriSalus Life Sciences is a biopharma company that specializes in treatment research and development for tumors of the liver and pancreas. TriSalus involves a team of clinicians and scientists who develop systemic immunotherapies to fight tumors through its developed drug delivery methods.

Learn more about TriSalus Life Sciences IPO

Enterprise Value

Access valuation and stock price for companies like TriSalus Life Sciences before its SPAC.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

TriSalus Life Sciences stock FAQs

Can you buy TriSalus Life Sciences stock?

You can no longer buy TriSalus Life Sciences stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy TriSalus Life Sciences stock?

To invest in a private company like TriSalus Life Sciences through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell TriSalus Life Sciences stock?

You can no longer sell stock of TriSalus Life Sciences on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell TriSalus Life Sciences stock?

If you hold private company shares of TriSalus Life Sciences - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your TriSalus Life Sciences stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is TriSalus Life Sciences a public company?

No, TriSalus Life Sciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is TriSalus Life Sciences’ stock price?

The stock price of TriSalus Life Sciences is $8.3 as of 1/18/24.

What is TriSalus Life Sciences’ stock ticker symbol?

The ticker symbol of TriSalus Life Sciences is TLSI.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Mary Szela

Chief Executive Officer and President

Steven C. Katz, MD, FACS

Chief Medical Officer, Scientific Advisory Board Chairman

Sean Murphy

Chief Financial Officer

Trevor McCaw

Chief Commercial Officer

Bryan F. Cox, PhD

Chief of Research

Jennifer L. Stevens, JD

Chief Regulatory Officer

Richard B. Marshak VMD, MBA

Business Development & Strategy, SVP

Board Members

Beverly Huss

Vibrynt

Sean Murphy

Malin Corporation

John Tullis

Tullis Health Partners

Norman Weldon

Partison Management Group

Karen Cassidy

Partisan Management Group

Mark T. Lupa

High Country Venture

Ginger Graham

Independent Director

Mats Wahlstrom

KMG Capital Partners

Pharmaceutical Technology 08/11/2023

TriSalus merges with MedTech Acquisition to bolster cash reserves

TriSalus Life Sciences has merged with MedTech Acquisition Corporation to increase their cash reserves and fund developmental and commercial milestones. The merged company will trade on Nasdaq under the symbols "TLSI" and "TLSIW". The merger is expected to provide a cash runway until mid-2024 to support various plans, including the development of a cancer therapy.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.